Search

Search


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Search results for {{term}}

156. The BioHub Birmingham® Hosts National Life Science Event: BioBrum – 16

The BioHub Birmingham® Hosts National Life Science Event: BioBrum – 16th February 201715/12/2016Birmingham, UK – The BioHub Birmingham®, Birmingham’s flagship life science incubator, is hosting its first BioBrum Life Science event on 16th February 2017.  Aimed at pre-revenue life science companies the free event will include talks on finance, intellectual property, effective use of professional networks and business development.  There will also be an o


157. Takeda to Acquire ARIAD Pharmaceuticals, Inc. 

Takeda to Acquire ARIAD Pharmaceuticals, Inc.09/01/2017Cambridge, USA & Osaka, Japan – Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which Takeda will acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, or an enterprise value of approximately $5.2 billion. The transaction has been approved unanimously by the boards of directors of both companies, and is expecte


158. AMSBIO Launches New Ready-to-use Adeno-Associated Virus Biosensors

AMSBIO Launches New Ready-to-use Adeno-Associated Virus Biosensors19/01/2017 Abingdon, UK – AMSBIO announce a new range of ready-to-use adeno-associated virus (AAV) biosensor products. These viruses encode your chosen biosensor, either calcium or glutamate sensor and are ready for in vivo injection.The new range of Calcium or Glutamate biosensor products comes with a choice of promoter and the ability to include the Cre inducible (FLEx-ON) expression. AMSBIO have packaged these indica


159. Oxford Finance Provides $10 Million Senior Debt Facility to Oxford Bio

Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics26/01/2017 Alexandria & San Jose, USA and Oxford, UK – Oxford Finance LLC, an industry-leading specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $10 million senior secured term loan with Oxford BioTherapeutics (“OBT”), an international, clinical-stage biotechnology company focused on develop


160. Contractor appointed for £13 million landmark Oxford scheme

Contractor appointed for £13 million landmark Oxford scheme08/02/2017The Oxford Science Park has awarded a £13 million design and build contract for Plot 12, a new state of the art office building, capable of housing laboratories, and with roof terrace, comprising 61,500 sq ft (5,713 sq m), to Barnwood Construction Ltd.Gloucestershire-based Barnwood Construction has delivered commercial office and laboratory projects for many clients across southern and central England including: MEPC,



Page 32 of 44 ( 219 results in total )
© Catalyst Innovation Portal 2019